Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV

There is uncertainty regarding the potential virologic outcome associated with a change in antiretroviral therapy (ARV) among PLHIV who had previous documented virologic failure or who have been exposure to mono/dual nucleoside reverse transcriptase inhibitors (NRTI) therapy. The objective was to me...

Descripción completa

Detalles Bibliográficos
Autores principales: Sangaré, Mohamed N’dongo, Baril, Jean-Guy, de Pokomandy, Alexandra, Laprise, Claudie, Deshaies, Catherine, Klein, Marina, Thomas, Réjean, Tremblay, Cécile, Roger, Michel, Pexos, Costa, Greenwald, Zoe, Machouf, Nima, Durand, Madeleine, Hardy, Isabelle, Dakouo, Mamadou, Laporte, Louise, Trottier, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676601/
https://www.ncbi.nlm.nih.gov/pubmed/33217873
http://dx.doi.org/10.1097/MD.0000000000023335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676601/
https://www.ncbi.nlm.nih.gov/pubmed/33217873
http://dx.doi.org/10.1097/MD.0000000000023335

Ejemplares similares